Fund Management at Engine No 1’s Vertex Pharmaceuticals VRTX Stock Holding History

Fund Management at Engine No 1’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,692	Closed	-$1.28M	–	402
2023 Q3	$1.28M	Buy	3,692 +339	+10%	+$119K	0.2%	104
2023 Q2	$1.18M	Buy	3,353 +235	+8%	+$79.2K	0.22%	101
2023 Q1	$982K	Buy	3,118 +292	+10%	+$87.6K	0.2%	107
2022 Q4	$816K	Buy	2,826 +360	+15%	+$110K	0.2%	115
2022 Q3	$714K	Sell	2,466 -116	-4%	-$33.4K	0.21%	103
2022 Q2	$728K	Buy	2,582 +426	+20%	+$114K	0.19%	116
2022 Q1	$563K	Buy	+2,156	New	+$512K	0.14%	144

Other funds holding VRTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fund Management at Engine No 1's VRTX Position: Q4 2023 in Review

Fund Management at Engine No 1 sold out of Vertex Pharmaceuticals (VRTX) in Q4 2023, closing a stake of 3,692 shares — an estimated $1.28M sold.

Fund Management at Engine No 1 first reported a position in VRTX in Q1 2022 and held it in 7 quarters. The position peaked at $1.28M in Q3 2023. 1,438 funds tracked by Wall St. Rank hold VRTX as of Q4 2023.

Fund Management at Engine No 1 reported no remaining Vertex Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Fund Management at Engine No 1 sold 3,692 Vertex Pharmaceuticals shares in Q4 2023, an estimated $1.28M.
Fund Management at Engine No 1 first reported a position in Vertex Pharmaceuticals in Q1 2022 and held it in 7 quarters.
Fund Management at Engine No 1's Vertex Pharmaceuticals position peaked at $1.28M in Q3 2023.
1,438 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2023.

Based on Fund Management at Engine No 1's 13F filing for Q4 2023.